Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal Nicotine on Cognitive Function in Non-Smokers With and Without Schizophrenia
NCT00383747Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Apr 2004
- Primary completion
- Jan 2009
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in schizophrenia comparing Nicotine Patch First with Placebo Patch First (2 arms). Primary endpoint: Continuous Performance Test Identical Pairs Version. Started Apr 2004; status: completed.
02
Drugs
nicotine patch
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00383747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00383747.